Literature DB >> 30157397

Langerhans-Cell Histiocytosis.

Carl E Allen1, Miriam Merad1, Kenneth L McClain1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30157397      PMCID： PMC6334777          DOI： 10.1056/NEJMra1607548

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  90 in total

1.  Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules.

Authors:  J Valladeau; O Ravel; C Dezutter-Dambuyant; K Moore; M Kleijmeer; Y Liu; V Duvert-Frances; C Vincent; D Schmitt; J Davoust; C Caux; S Lebecque; S Saeland
Journal:  Immunity       Date:  2000-01       Impact factor: 31.745

2.  Langerhans cell histiocytosis: an evaluation of histopathological parameters, demonstration of proliferation by Ki-67 and mitotic bodies.

Authors:  Micha I Bank; Pia Rengtved; Henrik Carstensen; Bodil L Petersen
Journal:  APMIS       Date:  2003-02       Impact factor: 3.205

3.  Langerhans cells renew in the skin throughout life under steady-state conditions.

Authors:  Miriam Merad; Markus G Manz; Holger Karsunky; Amy Wagers; Wendy Peters; Israel Charo; Irving L Weissman; Jason G Cyster; Edgar G Engleman
Journal:  Nat Immunol       Date:  2002-11-04       Impact factor: 25.606

4.  Histiocytosis X; integration of eosinophilic granuloma of bone, Letterer-Siwe disease, and Schüller-Christian disease as related manifestations of a single nosologic entity.

Authors:  L LICHTENSTEIN
Journal:  AMA Arch Pathol       Date:  1953-07

5.  Treatment of multisystem Langerhans cell histiocytosis. Results of the DAL-HX 83 and DAL-HX 90 studies. DAL-HX Study Group.

Authors:  M Minkov; N Grois; A Heitger; U Pötschger; T Westermeier; H Gadner
Journal:  Klin Padiatr       Date:  2000 Jul-Aug       Impact factor: 1.349

6.  A randomized trial of treatment for multisystem Langerhans' cell histiocytosis.

Authors:  H Gadner; N Grois; M Arico; V Broadbent; A Ceci; A Jakobson; D Komp; J Michaelis; S Nicholson; U Pötschger; J Pritchard; S Ladisch
Journal:  J Pediatr       Date:  2001-05       Impact factor: 4.406

7.  Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases.

Authors:  S A Pileri; T M Grogan; N L Harris; P Banks; E Campo; J K C Chan; R D Favera; G Delsol; C De Wolf-Peeters; B Falini; R D Gascoyne; P Gaulard; K C Gatter; P G Isaacson; E S Jaffe; P Kluin; D M Knowles; D Y Mason; S Mori; H-K Müller-Hermelink; M A Piris; E Ralfkiaer; H Stein; I-J Su; R A Warnke; L M Weiss
Journal:  Histopathology       Date:  2002-07       Impact factor: 5.087

8.  Langerhans cell histiocytosis in adults. Report from the International Registry of the Histiocyte Society.

Authors:  M Aricò; M Girschikofsky; T Généreau; C Klersy; K McClain; N Grois; J-F Emile; E Lukina; E De Juli; C Danesino
Journal:  Eur J Cancer       Date:  2003-11       Impact factor: 9.162

9.  Langerhans-cell histiocytosis 'insight into DC biology'.

Authors:  Jon D Laman; Pieter J M Leenen; Nicola E Annels; Pancras C W Hogendoorn; R Maarten Egeler
Journal:  Trends Immunol       Date:  2003-04       Impact factor: 16.687

10.  Mutations of the BRAF gene in human cancer.

Authors:  Helen Davies; Graham R Bignell; Charles Cox; Philip Stephens; Sarah Edkins; Sheila Clegg; Jon Teague; Hayley Woffendin; Mathew J Garnett; William Bottomley; Neil Davis; Ed Dicks; Rebecca Ewing; Yvonne Floyd; Kristian Gray; Sarah Hall; Rachel Hawes; Jaime Hughes; Vivian Kosmidou; Andrew Menzies; Catherine Mould; Adrian Parker; Claire Stevens; Stephen Watt; Steven Hooper; Rebecca Wilson; Hiran Jayatilake; Barry A Gusterson; Colin Cooper; Janet Shipley; Darren Hargrave; Katherine Pritchard-Jones; Norman Maitland; Georgia Chenevix-Trench; Gregory J Riggins; Darell D Bigner; Giuseppe Palmieri; Antonio Cossu; Adrienne Flanagan; Andrew Nicholson; Judy W C Ho; Suet Y Leung; Siu T Yuen; Barbara L Weber; Hilliard F Seigler; Timothy L Darrow; Hugh Paterson; Richard Marais; Christopher J Marshall; Richard Wooster; Michael R Stratton; P Andrew Futreal
Journal:  Nature       Date:  2002-06-09       Impact factor: 49.962
View more
  73 in total

1.  Clinical responses and persistent BRAF V600E+ blood cells in children with LCH treated with MAPK pathway inhibition.

Authors:  Olive S Eckstein; Johannes Visser; Carlos Rodriguez-Galindo; Carl E Allen
Journal:  Blood       Date:  2019-02-04       Impact factor: 22.113

2.  Revealing a rare inflammatory oral manifestation in a 6-year-old child.

Authors:  Samapika Routray; Amit Kumar Adhya; Joseph John; Punit Dikhit
Journal:  BMJ Case Rep       Date:  2019-07-23

Review 3.  Childhood Langerhans cell histiocytosis: a disease with many faces.

Authors:  Alexander K C Leung; Joseph M Lam; Kin Fon Leong
Journal:  World J Pediatr       Date:  2019-08-28       Impact factor: 2.764

4.  Histiocytic disorders: insights into novel biology and implications for therapy of Langerhans cell histiocytosis and Erdheim-Chester disease.

Authors:  Kenneth McClain
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2020-12-04

5.  Epstein-Barr Virus-Associated Langerhans Cell Histiocytosis of the Thyroid Gland.

Authors:  Jijgee Munkhdelger; Patravoot Vatanasapt; Chamsai Pientong; Somboon Keelawat; Andrey Bychkov
Journal:  Head Neck Pathol       Date:  2020-11-02

6.  MAPK mutations and cigarette smoke promote the pathogenesis of pulmonary Langerhans cell histiocytosis.

Authors:  Huan Liu; Andrew R Osterburg; Jennifer Flury; Zulma Swank; Dennis W McGraw; Nishant Gupta; Kathryn A Wikenheiser-Brokamp; Ashish Kumar; Abdellatif Tazi; Yoshikazu Inoue; Masaki Hirose; Francis X McCormack; Michael T Borchers
Journal:  JCI Insight       Date:  2020-02-27

7.  Management of severe pulmonary Langerhans cell histiocytosis in children.

Authors:  Olive S Eckstein; Jed G Nuchtern; George B Mallory; R Paul Guillerman; Matthew A Musick; Mhairi Barclay; Jayesh M Bhatt; Patrick Davies; Richard G Grundy; Alice Martin; Tom Hilliard; Stephen P Lowis; Susan Picton; Vasanta Nanduri; Johannes Visser; Carl E Allen; Kenneth L McClain
Journal:  Pediatr Pulmonol       Date:  2020-06-08

8.  Epigenomics and Single-Cell Sequencing Define a Developmental Hierarchy in Langerhans Cell Histiocytosis.

Authors:  Florian Halbritter; Matthias Farlik; Raphaela Schwentner; Gunhild Jug; Nikolaus Fortelny; Thomas Schnöller; Hanja Pisa; Linda C Schuster; Andrea Reinprecht; Thomas Czech; Johannes Gojo; Wolfgang Holter; Milen Minkov; Wolfgang M Bauer; Ingrid Simonitsch-Klupp; Christoph Bock; Caroline Hutter
Journal:  Cancer Discov       Date:  2019-07-25       Impact factor: 39.397

Review 9.  Understanding and Classification of Ocular Lymphomas.

Authors:  Valerie A White
Journal:  Ocul Oncol Pathol       Date:  2019-05-16

10.  Circulating CD1c+ myeloid dendritic cells are potential precursors to LCH lesion CD1a+CD207+ cells.

Authors:  Karen Phaik Har Lim; Paul Milne; Michael Poidinger; Kaibo Duan; Howard Lin; Naomi McGovern; Harshal Abhyankar; Daniel Zinn; Thomas M Burke; Olive S Eckstein; Rikhia Chakraborty; Amel Sengal; Brooks Scull; Evan Newell; Miriam Merad; Kenneth L McClain; Tsz-Kwong Man; Florent Ginhoux; Matthew Collin; Carl E Allen
Journal:  Blood Adv       Date:  2020-01-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.